Cargando…

Evaluation of Recombinant Human Growth Hormone Secretion in E. coli using the L-asparaginase II Signal Peptide

BACKGROUND: In the recent years, there has been an increasing interest in secretory production of recombinant proteins, due to its various advantages compared with intracellular expression. Signal peptides play a critical role in prosperous secretion of recombinant proteins. Accordingly, different s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zamani, Mozhdeh, Nezafat, Navid, Ghasemi, Younes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Avicenna Research Institute 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124255/ https://www.ncbi.nlm.nih.gov/pubmed/27920886

Ejemplares similares

Refolding and purification of recombinant L-asparaginase from inclusion bodies of E. coli into active tetrameric protein
por: Upadhyay, Arun K., et al.
Publicado: (2014)

Opportunistic complexes of E. coli L-asparaginases with citrate anions
por: Lubkowski, Jacek, et al.
Publicado: (2019)

Quality comparison of a state-of-the-art preparation of a recombinant L-asparaginase derived from Escherichia coli with an alternative asparaginase product
por: Schnuchel, Arndt, et al.
Publicado: (2023)

Structural Aspects of E. coli Type II Asparaginase in Complex with Its Secondary Product L-Glutamate
por: Maggi, Maristella, et al.
Publicado: (2022)

Designing self-assembled peptide nanovaccine against Streptococcus pneumoniae: An in silico strategy
por: Dorosti, Hesam, et al.
Publicado: (2019)

Development of Processes for Recombinant L-Asparaginase II Production by Escherichia coli Bl21 (De3): From Shaker to Bioreactors
por: Barros, Thaís, et al.
Publicado: (2020)

Harnessing self-assembled peptide nanoparticles in epitope vaccine design
por: Negahdaripour, Manica, et al.
Publicado: (2017)

In silico design and evaluation of a novel mRNA vaccine against BK virus: a reverse vaccinology approach
por: Mohammadi, Yasaman, et al.
Publicado: (2022)

Efficacy and safety of PEG-asparaginase versus E. coli L-asparaginase in Chinese children with acute lymphoblastic leukemia: a meta-analysis
por: Dai, Zhan-Jing, et al.
Publicado: (2021)

Allergic Reactions to E. coli Asparaginase are Associated with Decreased Asparaginase Activity in an Indonesian Pediatric Population with ALL
por: Sari, Nur Melani, et al.
Publicado: (2023)

Expression of a recombinant bacterial l-asparaginase in human cells
por: Dantas, Raquel Caminha, et al.
Publicado: (2019)

Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli
por: Einsfeldt, Karen, et al.
Publicado: (2016)

SUPPRESSION OF MURINE LEUKEMIAS BY L-ASPARAGINASE : INCIDENCE OF SENSITIVITY AMONG LEUKEMIAS OF VARIOUS TYPES: COMPARATIVE INHIBITORY ACTIVITIES OF GUINEA PIG SERUML-ASPARAGINASE AND ESCHERICHIA COLI L-ASPARAGINASE
por: Boyse, Edward A., et al.
Publicado: (1967)

Fed-Batch Production of Saccharomyces cerevisiae L-Asparaginase II by Recombinant Pichia pastoris MUT(s) Strain
por: Rodrigues, David, et al.
Publicado: (2019)

Assessment of E. coli Expression System for Overexpression of Active Recombinant Ocriplasmin
por: Baghban, Roghayyeh, et al.
Publicado: (2021)

PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
por: Medawar, Camile Valle, et al.
Publicado: (2020)

Correction: Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli
por: Einsfeldt, Karen, et al.
Publicado: (2016)

Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase
por: Lorentz, Kristen M., et al.
Publicado: (2015)

Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli‐Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia
por: Vrooman, Lynda M., et al.
Publicado: (2015)

Expression and Biological Evaluation of an Engineered Recombinant L-asparaginase Designed by In Silico Method Based on Sequence of the Enzyme from Escherichia coli
por: Dastmalchi, Mahrokh, et al.
Publicado: (2023)

Anticancer Activity of Extremely Effective Recombinant L-Asparaginase from Burkholderia pseudomallei
por: Darwesh, Doaa B., et al.
Publicado: (2022)

Cloning, expression, purification and characterisation of Erwinia carotovora L-asparaginase in Escherichia coli
por: Pourhossein, Meraj, et al.
Publicado: (2014)

Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F)
por: Ardalan, Noeman, et al.
Publicado: (2021)

Deciphering Additional Roles for the EF-Tu, l-Asparaginase II and OmpT Proteins of Shiga Toxin-Producing Escherichia coli
por: Torres, Alexia N., et al.
Publicado: (2020)

Optimization of expression, purification and secretion of functional recombinant human growth hormone in Escherichia coli using modified staphylococcal protein a signal peptide
por: Rigi, Garshasb, et al.
Publicado: (2021)

High level expression and purification of recombinant flounder growth hormone in E. coli
por: Choi, Tae-Jin, et al.
Publicado: (2018)

Recombinant L-asparaginase 1 from Saccharomyces cerevisiae: an allosteric enzyme with antineoplastic activity
por: Costa, Iris Munhoz, et al.
Publicado: (2016)

L-Asparaginase from Penicillium sizovae Produced by a Recombinant Komagataella phaffii Strain
por: Freitas, Marcela, et al.
Publicado: (2022)

Screening for Type II L-Asparaginases: Lessons from the Genus Halomonas
por: Sharafi, Zeinab, et al.
Publicado: (2017)

Cloning, expression and characterization of l-asparaginase from Pseudomonas fluorescens for large scale production in E. coli BL21
por: Kishore, Vijay, et al.
Publicado: (2015)

Protein re-surfacing of E. coli L-Asparaginase to evade pre-existing anti-drug antibodies and hypersensitivity responses
por: Bootwala, Ali, et al.
Publicado: (2022)

The effects of nature‐inspired amino acid substitutions on structural and biochemical properties of the E. coli L‐asparaginase EcAIII
por: Janicki, Maciej, et al.
Publicado: (2023)

Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
por: Khalil, Alaeddin, et al.
Publicado: (2020)

Revealing Escherichia coli type II l-asparaginase active site flexible loop in its open, ligand-free conformation
por: Maggi, Maristella, et al.
Publicado: (2021)

Designing a Multi-Epitope Antigen for Serodiagnosis of Strongyloides stercoralis Based on L3Nie.01 and IgG Immunoreactive Epitopes
por: Movahedpour, Ahmad, et al.
Publicado: (2022)

E. coli-Derived L-Asparaginase Retains Enzymatic and Cytotoxic Activity In Vitro for Canine and Feline Lymphoma after Cold Storage
por: Wypij, Jackie M., et al.
Publicado: (2013)

Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study
por: Liu, Wen-jian, et al.
Publicado: (2016)

Diabetes ketoacidosis in L-asparaginase therapy
por: Mabulac, Marichu P, et al.
Publicado: (2013)

In silico analysis of suitable signal peptides for secretion of a recombinant alcohol dehydrogenase with a key role in atorvastatin enzymatic synthesis
por: Taheri-Anganeh, Mortaza, et al.
Publicado: (2019)

Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Kim, Hyun Jee, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_denji9v3l42i7q388co0ankb4g